T cell antigen receptors, t cells specific for lmp2, and uses thereof
CN122277702APending Publication Date: 2026-06-26BEIJING HUIDA BIOTECHNOLOGY CO LTD
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING HUIDA BIOTECHNOLOGY CO LTD
- Filing Date
- 2024-12-25
- Publication Date
- 2026-06-26
Smart Images

Figure CN122277702A_ABST
Abstract
This invention provides a T-cell antigen receptor, LMP2-specific T cells, and their applications. This T-cell antigen receptor specifically recognizes EBV antigens and is composed of a TCRα chain and a TCRβ chain, wherein the TCRα chain contains CDR1α, CDR2α, and CDR3α; and the TCRβ chain contains CDR1β, CDR2β, and CDR3β. The T-cell antigen receptor provided by this invention binds to the EBV latent membrane protein LMP2. T cells transduced with this TCR can specifically recognize the corresponding pMHC complex, generating high levels of TCR-T cell activation and exhibiting significant functional activity against EBV-infected target cells, thus treating EBV-related diseases.
Need to check novelty before this filing date? Find Prior Art